In the BioHarmony Drug Report Database
Desonide
Desonate, Desonide, Desowen, Verdeso, Jorveza (desonide) is a small molecule pharmaceutical. Desonide was first approved as Desonate on 1982-01-01. It is used to treat facial dermatoses, foot dermatoses, hand dermatoses, inflammation, and leg dermatoses amongst others in the USA. It has been approved in Europe to treat esophageal diseases. Desowen’s patent is valid until 2027-08-13 (FDA).
Trade Name
|
Jorveza |
|---|---|
Common Name
|
desonide |
ChEMBL ID
|
CHEMBL1201109 |
Indication
|
esophageal diseases, facial dermatoses, foot dermatoses, hand dermatoses, inflammation, leg dermatoses, scalp dermatoses |
Drug Class
|
Topical steroids (acetal derivatives) |
Image (chem structure or protein)